Venture capital investment in Asia ... companies attracted capital and stole the limelight, according to KPMG. Funding across the region dropped 32 per cent to US$12.9 billion from the preceding ...

Sun Pharmaceutical ... funding to develop a deuterated ruxolitinib treatment for hair loss. The Federal Circuit majority found that this “expression of intent,” including allocation of ...

In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Bio-Techne Corporation (NASDAQ:TECH).Bio-Techne Corporation (NASDAQ:TECH), with a market ...

A venture capitalist (VC) is a private equity investor who provides capital to companies with high growth potential in exchange for an equity stake. VC investments typically involve funding ...

data-driven analysis of the global Venture Debt (VD) and Growth Lending (GL) landscape across India, the GCC, Southeast Asia, and Europe. As venture capital funding becomes selective, alternative ...

The report presents the most comprehensive, data-driven analysis of ... en/ Global Venture Debt Report 2025 By Stride Ventures and Kearney As venture capital funding becomes selective, alternative ...

Venture capital funding in the quarter ending in March hit $3 billion for the first time since the second quarter of 2022. The average asking rate for space was $73.44 per square foot, according ...

Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company ... around $35 million in a private Series B funding round, likely closing in Q3.

The pharmaceutical industry experienced a period ... The biotech industry was hit hard because of the fall in venture capital and financing that companies in the space need to tap into regularly ...

A proprietary trading firm invests its own capital and balance sheet to conduct ... merger arbitrage, fundamental analysis, volatility arbitrage, technical analysis, and/or global macro trading.

In addition, there are the Vivo Capital-backed biotechs that were acquired by big pharma companies in recent years ... The $740m secured by Vivo Capital comes during a lull in venture capital funding ...